XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information
9 Months Ended
Mar. 31, 2018
Segment Information [Abstract]  
Segment Information

Note 10 – Segment Information

 

We manage our Company and aggregate our operational and financial information in two reportable segments: Aytu and Aytu Women’s Health. The Aytu segment consists of our core male urology products. The Aytu Women’s Health segment contains our women’s health products. Select financial information for these segments is as follows:

 

  Three Months Ended
March 31
  Nine Months Ended
March 31
 
  2018  2017  2018  2017 
Consolidated revenue:            
Aytu $561,000  $894,000  $2,518,000  $2,386,000 
Aytu Women's Health  46,000   -   217,000   - 
                 
Consolidated revenue $607,000  $894,000  $2,735,000  $2,386,000 
                 
Consolidated net loss:                
Aytu $(1,539,000) $(5,216,000) $(8,414,000) $(15,758,000)
Aytu Women's Health  (1,279,000)  -   (2,321,000)  - 
                 
Consolidated net loss $(2,818,000) $(5,216,000) $(10,735,000) $(15,758,000)
                 
Total consolidated assets:                
Aytu $23,299,000  $15,917,000  $23,299,000  $15,917,000 
Aytu Women's Health  76,000   -   76,000   - 
                 
Total consolidated assets $23,375,000  $15,917,000  $23,375,000  $15,917,000